CD19 and neoplasm: The results revealed a multifaceted mechanism of action, which facilitated the enhanced infiltration of endogenous T-cells into the tumor sites, improved CAR T-cell recruitment within the tumor microenvironment, and enabled CD19-CAR T-cells to trigger the release of intact virus particles from dying cancer cells [163].